CAW
ANGO icon

Cornerstone Advisors (Washington)’s AngioDynamics ANGO Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-64
Closed -$1K – 826
2019
Q2 		$1K Buy
64
+31
+94% +$631 ﹤0.01% 1243
2019
Q1 		$1K Buy
+33
New +$716 ﹤0.01% 1113

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Cornerstone Advisors (Washington)'s ANGO Position: Q3 2019 in Review

Cornerstone Advisors (Washington) sold out of AngioDynamics (ANGO) in Q3 2019, closing a stake of 64 shares — an estimated $1K sold.

Cornerstone Advisors (Washington) first reported a position in ANGO in Q1 2019 and held it in 2 quarters. The position peaked at $1K in Q2 2019. 173 funds tracked by Wall St. Rank hold ANGO as of Q3 2019.

  • Cornerstone Advisors (Washington) reported no remaining AngioDynamics position as of Q3 2019 after selling out during the quarter.
  • Cornerstone Advisors (Washington) sold 64 AngioDynamics shares in Q3 2019, an estimated $1K.
  • Cornerstone Advisors (Washington) first reported a position in AngioDynamics in Q1 2019 and held it in 2 quarters.
  • Cornerstone Advisors (Washington)'s AngioDynamics position peaked at $1K in Q2 2019.
  • 173 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2019.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2019, filed 23 Oct 2019.